BiomX, Inc. (PHGE)
0.632
-0.01
(-1.70%)
USD |
NYAM |
May 13, 10:08
BiomX EPS Diluted (Quarterly) : -8.369 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Protagonist Therapeutics, Inc. | 0.0537 |
| ACADIA Pharmaceuticals, Inc. | 0.0211 |
| Alnylam Pharmaceuticals, Inc. | 1.508 |
| Amgen, Inc. | 3.344 |
| Savara, Inc. | -0.1341 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -13.34M |
| Total Expenses (Quarterly) | 13.34M |
| Enterprise Value | 16.08M |
| Earnings Yield | -3.78K% |
| Normalized Earnings Yield | -3497.97 |